M&A Deal Summary |
|
---|---|
Date | 1995-11-29 |
Target | Univax Biologics |
Sector | Life Science |
Buyer(s) | Nabi Biopharmaceuticals |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1967 |
Sector | Life Science |
Employees | 16 |
Nabi Biopharmaceuticals (NABI) has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, autoimmune and addictive diseases, such as Staphylococcus aureus and hepatitis infections, and nicotine addiction.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Maryland) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (1995) | 1 of 1 |